Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection

Journal of Experimental Medicine

Volumn 193, Issue 2, 2001, Pages 181-193

  Goulder, Philip J R ^a,b   Altfeld, Marcus A ^a   Rosenberg, Eric S ^a   Nguyen, Thi ^a   Tang, Yanhua ^a   Eldridge, Robert L ^a   Addo, Marylyn M ^a   He, Suqin ^a   Muckerjee, Joia S ^a   Phillips, Mary N ^a   Bunce, Michael ^c   Kalams, Spyros A ^a   Sekaly, Rafick P ^d   Walker, Bruce D ^a   Brander, Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Acute; Chronic; Epitope targeting; HIV infection; Immunodominance

Indexed keywords

EPITOPE; HLA A ANTIGEN;

ADULT; ARTICLE; CELL SPECIFICITY; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0035862326     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.2.181     Document Type: Article

References (83)

1. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of CTL clones
2. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
3. Analysis of successful immune responses in patients with hepatitis C virus
4. + T cells associated with the control of infection
5. Anti-human immunodeficiency virus cellular immunity: Progress towards vaccine design
6. Immunology taught by viruses
7. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus
8. Analysis of a successful immune response against hepatitis C virus
9. + lymphocytes
10. What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
11. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
12. + T-cell responses associated with control of viraemia
13. Immune control of HIV-1 after early treatment of acute infection
14. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
15. Tat-specific T lymphocytes select for SIV escape variants during resolution of primary viraemia
16. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections
17. + CTL activity associated with control of viremia in primary HIV infection
18. Temporal association of cellular immune responses with the initial control of viremia in primary HIV infection
19. HIV-specific T lymphocytes in seropositive individuals
20. Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term, asymptomatics
21. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes
22. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
23. Association between virus-specific CTL and helper responses in HIV-1 infection
24. + lymphocyte response in acutely infected rhesus monkeys
25. + T cell depletion in SIV-infected macaques
26. Virus-specific cytotoxic T-lymphocyte responses select for amino acid variation in simian immunodeficiency virus Env and Nef
27. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
28. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
29. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
30. Late escape from all immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
31. Influence of human MHC genes on the course of HIV infection
32. Consistent associations of HLA class 1 and 11 and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men
33. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
34. Novel, cross-restricted, conserved and immunodominant CTL epitopes in long-term slow progressors in HIV-1 infection
35. HLA-B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long-term nonprogressors
36. The immunogenetics of human infectious diseases
37. Protective immunity does not correlate with the hierarchy of virus-specific CTL responses to naturally processed peptides
38. Viral immune evasion due to persistence of activated T cells without effector function
39. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class l-peptide complexes
40. HIV-1 gagspecific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells
41. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1
42. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals
43. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term non-progressing HIV-1 infected individual
44. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two HLA-identical siblings with HLA-A*0201 are influenced by epitope mutation
45. Lack of strong immune selection pressure by the immunodominant HLA-A*0201 restricted CTL response in chronic HIV-1 infection
46. + T cells in individuals receiving highly active antiretroviral therapy
47. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
48. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study
49. Phototyping: Comprehensive DNA typing for HLA-A B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
50. Recent advances in the optimization of HIV-specific C.T.L. epitopes
51. + memory T cells
52. Differential narrow focusing of immunodominant HIV Gag-specific CTL responses in infected African and Caucasoid adults and children
53. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
54. Functionally inert HIV-specific cytotoxic T lymphocyte do not play a major role in chronically infected adults and children
55. + T-cell responses cannot be predicted by major histocompatibility complex class 1 haplotype
56. BirA enzyme: Production and application in the study of membrane receptor-ligand interactions by site specific biotinylation
57. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1
58. HIV-1-specific cytotoxic T lymphocytes
59. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
60. + T cells specific for EBV in healthy virus carriers
61. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response
62. The human cytotoxic T-lymphocyte response to cytomegalovirusis dominated by structural protein pp65: Frequency, specificity and T-cell receptor usage of pp65-specific CTL
63. Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors
64. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women
65. + population
66. Efficient processing of the immunodominant HLA-A*0201-restricted HIV-1 CTL epitope despite multiple variations in the epitope flanking sequences
67. Frequency and epitope specificity of CTL elicited in uninfected recipients of candidate AIDS vaccines in AVEG Phase I/II studies: Comparison with CTL responses to HIV infection
68. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
69. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic LCMV infection
70. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
71. Antigen processing in vivo and the elicitation of primary C.T.L. responses
72. Antigenic oscillations and shifting immunodominance in HIV-1 infections
73. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaenous presentation of agonist and antagonist peptides
74. Characterization of peptides bound to rhew class I molecule HLA-A2.1 by mass spectrometry
75. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
76. Identification of novel HLA-A2-restricted HIV-1-specific CTL epitopes predicted by the HLA-A2 supertype peptide-binding motif
77. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes
78. Underestimated role of HLA-C-restricted CTL epitopes in the anti-HIV immune response
79. Combined structural and immunological refinement of CTL epitopes
80. Levels of HIV-1-specific CTL effector and memory, responses decline after suppression of viremia with highly active antiretroviral therapy
81. + T cells during the primary immune response to Epstein-Barr virus in vivo
82. + T-cell effector activity in HIV primary infection
83. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained